Evidence map›Paper›PMID 41658099›Full record

ArticleACS omega2026

Laboratory and Field Evaluation of Graphene Oxide and Silver Nanoparticle-Enhanced Silicone Fouling Release and Biocidal Coatings for Marine Antifouling.

Michael R Kelly, Olaug M Aalen, Ingrid G Hallsteinsen, Hilde L Lein

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael R KellyDepartment of Materials Science and Engineering, Norwegian University of Science and Technology NTNU, Sem Sælands vei 12, 7034 Trondheim, Norway.ORCID https://orcid.org/0009-0009-2238-0546
Olaug M AalenDepartment of Materials Science and Engineering, Norwegian University of Science and Technology NTNU, Sem Sælands vei 12, 7034 Trondheim, Norway.
Ingrid G HallsteinsenDepartment of Materials Science and Engineering, Norwegian University of Science and Technology NTNU, Sem Sælands vei 12, 7034 Trondheim, Norway.
Hilde L LeinDepartment of Materials Science and Engineering, Norwegian University of Science and Technology NTNU, Sem Sælands vei 12, 7034 Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study explores the enhancement of silicone-based fouling release coatings through the incorporation of graphene oxide and silver nanoparticles. Laboratory tests demonstrated significantly improved microfouling resistance with increasing nanoparticle concentrations while maintaining surface energies within the optimal range for fouling release. During a 7 month marine field immersion trial, only the silver nanoparticle-containing composite coating exhibited improved antifouling efficacy over time, while the performance of the graphene oxide-containing composite coating was comparable to the simplified nonbiocidal fouling release coating. Both composite coatings showed a slightly earlier onset of macrofouling. Microscopy revealed notable nanoparticle agglomeration and localized algal attachment, emphasizing the need for improved dispersion and surface integration. Though the addition of nanoparticles for boosting antifouling efficacy with both biocidal and fouling release strategies showed only marginal improvements, clear evidence of enhanced performance is seen. Advancing this technology demands targeted control over nanoparticle distribution and leaching, which are key challenges that must be addressed to unlock the full potential of next-generation, sustainable antifouling coatings.

Identifiers

PMID41658099
PMCPMC12878346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.